{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:37:06Z","timestamp":1794623826684,"version":"4.9.1"},"reference-count":5,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2026,4,4]]},"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1136\/jnnp-2026-338722","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:20:26Z","timestamp":1776446426000},"page":"568-568","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Comparing amyloid immunotherapy with cholinesterase inhibitors for Alzheimer\u2019s disease"],"prefix":"10.1136","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0472-870X","authenticated-orcid":false,"given":"Christopher R S","family":"Belder","sequence":"first","affiliation":[{"name":"School of Medicine, Adelaide University, Adelaide, South Australia, Australia"},{"name":"Department of Neurology, Royal Adelaide Hospital and Queen Elizabeth Hospital, Adelaide, South Australia, Australia"},{"name":"Dementia Research Centre, University College London, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick C","family":"Fox","sequence":"additional","affiliation":[{"name":"Dementia Research Centre, University College London, London, England, UK"},{"name":"UK Dementia Research Institute at UCL, UK DRI, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"2026102807300974000_97.7.568.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01329-7"},{"key":"2026102807300974000_97.7.568.2","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209320","article-title":"Lecanemab Questions","volume":"102","author":"Nadeau","year":"2024","journal-title":"Neurology (ECronicon)"},{"key":"2026102807300974000_97.7.568.3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2025-336691"},{"key":"2026102807300974000_97.7.568.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00335-1"},{"key":"2026102807300974000_97.7.568.5","doi-asserted-by":"crossref","unstructured":"van Dyck CH , Sperling R , Johnson K , et al . Long\u2010term safety and efficacy of lecanemab in early Alzheimer\u2019s disease: Results from the clarity AD open\u2010label extension study. Alzheimer's & Dementia 2025;21. doi:10.1002\/alz.70905","DOI":"10.1002\/alz.70905"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2026-338722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:30:24Z","timestamp":1793197824000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2026-338722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":5,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,6,12]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/jnnp-2026-338722"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2026-338722","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]}}}